Give Kids a Chance Act of 2024

Hozzl · 2024-10-04T20:07:38Z

Explore the details of House Bill 3433 Give Kids a Chance Act of 2024 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

10/4/2024, 8:07 PM

Summary of Bill HR 3433

Bill 118 hr 3433, also known as the Give Kids a Chance Act of 2024, aims to provide additional support and resources to children in underserved communities across the United States. The bill focuses on improving access to quality education, healthcare, and other essential services for children who may be facing economic or social disadvantages.

One key aspect of the bill is the establishment of grant programs to fund initiatives that support children's academic success, mental health, and overall well-being. These grants would be awarded to schools, community organizations, and other entities that work directly with children in need.

Additionally, the bill includes provisions to expand access to healthcare services for children, including mental health services and preventative care. This would help ensure that children in underserved communities receive the medical attention they need to thrive. Furthermore, the bill emphasizes the importance of early childhood education and aims to increase funding for programs that support young children's development. By investing in early education, the bill seeks to give children a strong foundation for future academic success. Overall, the Give Kids a Chance Act of 2024 is a comprehensive piece of legislation that seeks to address the needs of children in underserved communities and provide them with the support and resources necessary to succeed.

Congressional Summary of HR 3433

Give Kids a Chance Act of 2023

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3433

Bill HR 3433 is currently in the status of Bill Introduced since May 17, 2023. Bill HR 3433 was introduced during Congress 118 and was introduced to the House on May 17, 2023. Bill HR 3433's most recent activity was Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 24, 2024

Bipartisan Support of Bill HR 3433

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

470

Democrat Cosponsors

274

Republican Cosponsors

196

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 3433

Primary Policy Focus

Health

Potential Impact Areas

CancerChild healthCongressional oversightDrug safety, medical device, and laboratory regulationDrug therapyGovernment studies and investigationsMedical researchPrescription drugs

Alternate Title(s) of Bill HR 3433

Give Kids a Chance Act of 2024Give Kids a Chance Act of 2024Give Kids a Chance Act of 2024Give Kids a Chance Act of 2024Give Kids a Chance Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.

Start holding our government accountable!